AQR Capital Management has reduced its short position in the medical technology company Ambu to below 0.5 percent, meaning it is no longer publicly disclosed.
A total of 6.31 percent of Ambu’s capital is shorted, placing the company fifth among the most heavily shorted Danish companies.